… the impossible possible.” Donna Rajkovic was diagnosed with Early Onset Parkinson’s disease in 2012 after several years … and uncertainty. From the beginning, she believed that research holds the key to unlocking answers and changing the … What began around her kitchen table quickly grew into a grassroots movement fueled by heart, faith, and …

… sporadic PD patients’ derived dopamine neurons. Impact on Diagnosis/Treatment of Parkinson’s Disease:              The … of lipid biomarkers could lead to a new opportunity for early diagnosis of PD and to the development of new therapies …

… assays have been shown to enable an accurate and early diagnosis of Parkinson’s disease (PD). However, this … In this study, we propose to analyze existing skin samples from the MJFF Systemic Synuclein Sampling Study (S4). … of Parkinson’s disease:  If successful, we can compare the amplified alpha-synuclein from the S4 skin …

… including PD.  Despite the fact that we are still in the early stages of stem cell therapy development, The Michael … Nature that could have major implications on stem cell research in PD moving forward.  Lorenz Studer, MD , director … embryonic stem (ES) cells to graft human dopamine neurons into pre-clinical models of Parkinson’s disease (PD). …

… Jewish families play an important role in Parkinson’s research. Certain genetic changes linked with the disease … part in research studies, people are turning their heritage into hope — and helping scientists learn how to stop brain … study. By taking part, participants help researchers find early signs of Parkinson’s and develop new treatments aimed …

… drug developer focused on pre-clinical development and early stage strategy. With a history of successful lead … Dr. Holt has progressed multiple candidate compounds into clinical trials across his 10 years of experience in …